$Portola制药(PTLA)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2018-11-07 AccNo: 0001564590-18-028082 Size: 11 MB 网页链接
$Portola制药(PTLA)$ 8-K - Current report Filed: 2018-11-07 AccNo: 0001193125-18-320908 Size: 88 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Portola制药(PTLA)$ 美东时间 2018-11-07 盘后 披露财报,预期EPS -1.54 网页链接
$Portola制药(PTLA)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2018-10-18 AccNo: 0001193805-18-001244 Size: 105 KB 网页链接
$Portola制药(PTLA)$ 8-K - Current report Filed: 2018-10-12 AccNo: 0001193125-18-298428 Size: 117 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 9.01: Financial ...
$Portola制药(PTLA)$ 8-K - Current report Filed: 2018-09-20 AccNo: 0001193125-18-278139 Size: 43 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 9.01: Financial S...
$Portola制药(PTLA)$ 8-K - Current report Filed: 2018-09-07 AccNo: 0001193125-18-268689 Size: 15 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers 网页链接
$Portola制药(PTLA)$ 内部交易: 2018-08-31,Interim Co-总裁 & EVP R&D,Curnutte John T ,期权,17500普通股, $0.00
$Portola制药(PTLA)$ 内部交易: 2018-08-31,EVP, CBO,Fu Tao ,期权,20000普通股, $0.00
$Portola制药(PTLA)$ 内部交易: 2018-08-31,Interim Co-总裁 & CFO,Dier Mardi ,期权,17500普通股, $0.00